Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to dextroamphetamine.
- Mechanism
- Curator reviewed
Phenmetrazine is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron leading to an increase in the release of these monoamines into the extraneuronal space. Dopamine integrates incoming sensory stimuli, initiates and controls fine movement (nigro-neostriatal pathway), controls emotional behavior (midbrain mesolimbic-forebrain system) and controls hypothalamic-pituitary endocrine system (tubero-infundibular system). It is this latter effect on the tubero-infundibular systm that seems to lead to reduced food intake. Phenmetrazine also acts as a monoamine oxidase inhibitor.
- Primary indication
- Used as an anorectic in the treatment of obesity.Curator reviewed
- Formula / weight
- C11H15NO · 177.2429 g/mol (avg)
- Also known as
- Fenmetrazin · Phenmetrazin
- Code names
- PAL-592 · USAF Ge-1
Resolves to
OOBHFESNSZDWIU-UHFFFAOYSA-NSMILESCC1NCCOC1C1=CC=CC=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Phenmetrazine, and which of those have an active Phase 3 trial?